Evaluation of the oncology care model

Ended Awarded Last action

Contract number
HHSM500T0003
Awardee
Awarding agency
Obligated
$42,950,612

Award facts

Opportunity
Contract value 100% obligated
$42,950,612.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Award Fee
Place of performance
Windsor Mill, Milford Mill, MD 21244, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00014 $0
Other Administrative Action P00013 $0
Change Order P00012 $0
Other Administrative Action P00011 $0
Other Administrative Action P00010 $0
Other Administrative Action P00009 $0
Supplemental Agreement for work within scope P00008 $0
Exercise an Option P00007 $3,049,230
Other Administrative Action P00006 $0
Funding Only Action P00005 -$1,124,052
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Exercise an Option P00002 $6,006,752
Supplemental Agreement for work within scope P00001 $0
Supplemental Agreement for work within scope 2 $0
Supplemental Agreement for work within scope 1 $12,521,691
Original award $22,496,991
Show all 17

About this award

Written by GovTribe AI ·

ABT Global LLC, a subsidiary of ABT Associates Inc., was awarded a $42.95 million delivery order by the Centers for Medicare and Medicaid Services on December 28, 2015, for evaluation of the Oncology Care Model. The contract, which operates under a cost-plus award fee structure with no set-aside designation, is scheduled for completion by June 27, 2025, and will be performed in Windsor Mill and Milford Mill, Maryland. This delivery order is issued under the Research Measurement Assessment Design and Analysis (RMADA) master IDIQ vehicle, which enables CMS to procure specialized research and evaluation services. ABT Global LLC is well-positioned to conduct this evaluation, given its extensive experience as a research and consulting firm providing analytical, evaluation, and technical assistance services to federal health agencies, including previous work with the Centers for Disease Control and Prevention and other federal partners.

The Oncology Care Model evaluation represents a critical initiative to assess CMS's innovative payment and care delivery model designed to improve quality and reduce costs in cancer care. ABT Global LLC's subsidiary has demonstrated substantial capabilities in health policy research and program evaluation through its federal contracts and cooperative agreements across multiple agencies. The evaluation will leverage the firm's expertise in developing comprehensive analytical frameworks to measure model implementation, outcomes, and impact on participating oncology practices and beneficiaries, supporting CMS's efforts to refine and potentially scale payment innovations within the oncology sector.

Quick answers

Who was awarded contract HHSM500T0003?

HHSM500T0003 was awarded to ABT Global LLC by Centers for Medicare and Medicaid Services (Department of Health and Human Services) on December 28, 2015.

How much is contract HHSM500T0003 worth?

The government has obligated $42,950,612 on HHSM500T0003.

Is contract HHSM500T0003 an order under another contract?

Yes. HHSM500T0003 is a delivery order under HHSM500201400026I, an indefinite delivery contract, on Research Measurement Assessment Design and Analysis (RMADA).

Was contract HHSM500T0003 competed?

The extent of competition for HHSM500T0003 was full and open competition. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login